Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are AvailableMatthias Samwald, Richard D. Boyce, Hong Xu et al.|PLoS ONE|2016Cited by 81
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countriesEng Hooi Tan, Daniel Prieto‐Alhambra, Anthony G. Sena et al.|Lara D. Veeken|2021Cited by 53
Predictors of diagnostic transition from major depressive disorder to bipolar disorder: a retrospective observational network studyAnastasiya Nestsiarovich, Christophe G Lambert, Jenna Reps et al.|Translational Psychiatry|2021Cited by 51
Feasibility and evaluation of a large-scale external validation approach for patient-level prediction in an international data network: validation of models predicting stroke in female patients newly diagnosed with atrial fibrillationJenna Reps, Peter R. Rijnbeek, Ross D. Williams et al.|BMC Medical Research Methodology|2020Cited by 49
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DMRohan Khera, Marc A. Suchard, Lovedeep Singh Dhingra et al.|BMJ Medicine|2023Cited by 27